Zobrazeno 1 - 10
of 41
pro vyhledávání: '"L. Harmark"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ulrich Hagemann, Eugène van Puijenbroek, Kenneth Hartigan-Go, Alexander N. O. Dodoo, Anna Hegerius, Marco Tuccori, Marie Lindquist, Andrew Bate, L. Harmark, Juergen Beckmann
Publikováno v:
Drug Safety, 40(3), 191-199. ADIS INT LTD
The number of pharmacovigilance professionals worldwide is increasing with a high staff turnover. There is a constant stream of new colleagues with an interest or need to learn about the discipline. Consequently, there is an increasing need for train
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::299d87f9f02207fd0674976c881e9035
https://doi.org/10.1007/s40264-016-0495-9
https://doi.org/10.1007/s40264-016-0495-9
Publikováno v:
Drug Safety. 39:1105-1116
Patient reporting of adverse drug reactions (ADRs) to spontaneous reporting systems can make a valuable contribution to pharmacovigilance. However, the implementation and promotion of patient reporting systems (PRSs) differ worldwide.The objective of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343f134a799339fed2f96c4a5c627bd3
https://doi.org/10.1007/s40264-016-0453-6
https://doi.org/10.1007/s40264-016-0453-6
Autor:
Eugène van Puijenbroek, L. Harmark
Publikováno v:
Pharmacovigilance ISBN: 9783319403991
Over the past years, the scope of pharmacovigilance widened, allowing for better adjusted information on adverse drug reactions (ADRs) to the needs of regulators, clinicians and patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c419dbe22a0d3b962a64581beefbc981
https://doi.org/10.1007/978-3-319-40400-4_13
https://doi.org/10.1007/978-3-319-40400-4_13
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Drug Safety. 30:919-990
Background In August 2006, the Netherlands Pharmacovigilance Centre Lareb started with Lareb Intensive Monitoring (LIM). The main objective of LIM is to monitor the safety of new drugs. Patients eligible for participation are identified using the fir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54ca434d222c7853e057b6394adff432
https://doi.org/10.2165/00002018-200730100-00112
https://doi.org/10.2165/00002018-200730100-00112
Autor:
Ben W.J. Mol, H.P. van Geijn, Johannes J. Duvekot, Hans Wolf, Johannes Erwich, R. de Heus, L. Harmark, Myriam Hanssens, Wilfried Gyselaers, Gerard H. A. Visser, C.D. van Holsbeke, F.F.A.M. Schobben
Publikováno v:
The BMJ
British Medical Journal, 338. BMJ Publishing Group
Heus, R, Mol, B W, Erwich, J J, van Geijn, H, Gyselaers, W J, Hanssens, M, Harmark, L, van Holsbeke, C D, Duvekot, J J, Schobben, F F, de Wolf, H & Visser, G H A 2009, ' Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study ', British Medical Journal, vol. 338, no. b744, pp. 758-760 .
BMJ (Clinical research ed.), 338. British Medical Association
British Medical Journal, 338(b744), 758-760
British Medical Journal, 338(52):744. BMJ PUBLISHING GROUP
British Medical Journal, 338. BMJ Publishing Group
Heus, R, Mol, B W, Erwich, J J, van Geijn, H, Gyselaers, W J, Hanssens, M, Harmark, L, van Holsbeke, C D, Duvekot, J J, Schobben, F F, de Wolf, H & Visser, G H A 2009, ' Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study ', British Medical Journal, vol. 338, no. b744, pp. 758-760 .
BMJ (Clinical research ed.), 338. British Medical Association
British Medical Journal, 338(b744), 758-760
British Medical Journal, 338(52):744. BMJ PUBLISHING GROUP
Objective To evaluate the incidence of serious maternal complications after the use of various tocolytic drugs for the treatment of preterm labour in routine clinical situations.Design Prospective cohort study.Setting 28 hospitals in the Netherlands
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03ed6224902d2a21a4e87b4c5cb5a39f
http://europepmc.org/articles/PMC2654772
http://europepmc.org/articles/PMC2654772
Autor:
L. Harmark, A C van Grootheest
Publikováno v:
European journal of clinical pharmacology. 64(8)
Background Pharmacovigilance, defined by the World Health Organisation as 'the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem' plays a key role in ensuri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64905235f1e48e297a1250b2f123d73a
https://pubmed.ncbi.nlm.nih.gov/18523760
https://pubmed.ncbi.nlm.nih.gov/18523760
Autor:
Roychowdhury, Dibakar1 (AUTHOR) dibakarphys@gmail.com
Publikováno v:
European Physical Journal C -- Particles & Fields. Oct2023, Vol. 83 Issue 10, p1-8. 8p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.